[go: up one dir, main page]

PE20180025A1 - Nuevas formas solidas de desvenlafaxina - Google Patents

Nuevas formas solidas de desvenlafaxina

Info

Publication number
PE20180025A1
PE20180025A1 PE2017001162A PE2017001162A PE20180025A1 PE 20180025 A1 PE20180025 A1 PE 20180025A1 PE 2017001162 A PE2017001162 A PE 2017001162A PE 2017001162 A PE2017001162 A PE 2017001162A PE 20180025 A1 PE20180025 A1 PE 20180025A1
Authority
PE
Peru
Prior art keywords
desvenlafaxine
solid forms
new solid
desmethylvenlafaxine
dsv
Prior art date
Application number
PE2017001162A
Other languages
English (en)
Inventor
Chavez Jorge Guillermo Dominguez
Vasquez Karina Mondragon
Rojas Hugo Morales
Ruiz Dea Herrera
Herbert Hopfl
Martinez Reyna Reyes
Illescas Javier Hernandez
Pelaez Juan Pablo Senosiain
Original Assignee
Alparis Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alparis Sa De Cv filed Critical Alparis Sa De Cv
Publication of PE20180025A1 publication Critical patent/PE20180025A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0018—Evaporation of components of the mixture to be separated
    • B01D9/0022—Evaporation of components of the mixture to be separated by reducing pressure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L9/00—Supporting devices; Holding devices
    • B01L9/02—Laboratory benches or tables; Fittings therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0018—Evaporation of components of the mixture to be separated
    • B01D9/0031—Evaporation of components of the mixture to be separated by heating
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/004—Fractional crystallisation; Fractionating or rectifying columns
    • B01D9/0045—Washing of crystals, e.g. in wash columns
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/02—Crystallisation from solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Clinical Laboratory Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a formas solidas amorfas y cristalinas de desvenlafaxina (DSV o (+/-)-1-[2-(dimetilamino)-1-(4-hidroxifenil)etil]ciclohexanol) u O-desmetilvenlafaxina o desmetilvenlafaxina), y a sus sales, solvatos, hidratos y polimorfos de las mismas. Tambien esta referida a una composicion farmaceutica. Dicho compuesto es util en el tratamiento de la depresion y/o como inhibidor selectivo de la reabsorcion de serotonina y la norepinefrina asi como en los trastornos vasomotores asociados a la menopausia
PE2017001162A 2016-06-29 2017-06-27 Nuevas formas solidas de desvenlafaxina PE20180025A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016008646A MX367362B (es) 2016-06-29 2016-06-29 Nuevas formas solidas de desvenlafaxina.

Publications (1)

Publication Number Publication Date
PE20180025A1 true PE20180025A1 (es) 2018-01-09

Family

ID=60718150

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2017001162A PE20180025A1 (es) 2016-06-29 2017-06-27 Nuevas formas solidas de desvenlafaxina

Country Status (7)

Country Link
US (1) US10207982B2 (es)
CA (1) CA2972156C (es)
CO (1) CO2017006492A1 (es)
ES (1) ES2648369B2 (es)
MX (1) MX367362B (es)
PE (1) PE20180025A1 (es)
SV (1) SV2017005474A (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6197828B1 (en) 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
ATE397581T1 (de) 1999-04-06 2008-06-15 Sepracor Inc O-desmethylvenlafaxin-succinat
HN2002000030A (es) 2001-02-12 2004-06-07 Wyeth Corp Nueva sal succinato de o-desmetil-venlafaxina
US20110046231A1 (en) 2007-10-22 2011-02-24 Actavis Group Ptc Ehf Solid forms of (±)-o-desmethylvenlafaxine salts
EP2085377A1 (en) 2008-01-29 2009-08-05 LEK Pharmaceuticals D.D. Novel salts of O-desmethyl-venlafaxine
WO2009101458A2 (en) * 2008-02-14 2009-08-20 Egis Gyógyszergyár Nyilvánosan Működő New polymorph and amorphous forms of desvenlafaxine fumarate
IN2008CH00818A (es) * 2008-04-01 2009-10-09 Actavis Group Ptc Ehf
EP2119695A1 (en) 2008-05-16 2009-11-18 Krka Preparation of O-desmethylvenlafaxine salts
KR20100132069A (ko) * 2008-06-16 2010-12-16 테바 파마슈티컬 인더스트리즈 리미티드 Ｏ-데스메틸벤라팍신염의 고체 상태
CZ301503B6 (cs) 2008-11-27 2010-03-24 Zentiva, A. S. Zpusob prípravy desvenlafaxinu a jeho solí
CZ2009454A3 (cs) 2009-07-15 2010-11-10 Zentiva, K. S. Zpusob prípravy desvenlafaxinu a jeho solí
EP2340818A1 (en) 2009-12-23 2011-07-06 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of venlafaxine and celecoxib
US8481596B2 (en) * 2011-06-08 2013-07-09 Lupin Limited Polymomorph of desvenlafaxine benzoate

Also Published As

Publication number Publication date
SV2017005474A (es) 2017-10-12
CA2972156C (en) 2024-06-25
US20180002273A1 (en) 2018-01-04
MX367362B (es) 2019-08-16
ES2648369B2 (es) 2018-06-08
MX2016008646A (es) 2017-12-28
CA2972156A1 (en) 2017-12-29
CO2017006492A1 (es) 2018-01-05
US10207982B2 (en) 2019-02-19
ES2648369A1 (es) 2018-01-02

Similar Documents

Publication Publication Date Title
CR11420A (es) Moduladores de gpr40 bifenilo sustituidos
CL2017002153A1 (es) Compuestos bicíclicos de sulfonamida cetona
ECSP13012770A (es) Formas cristalinas de 5-cloro-n2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina
MX2017002013A (es) Polimorfos de selinexor.
CL2019001066A1 (es) Sal de (s)-csa de s-ketamina, sal de (r)-csa de s-ketamina y procesos para la preparación de s-ketamina (divisional solicitud 201702854)
EA201692052A1 (ru) Циклопропанаминовое соединение и его применение
PE20181007A1 (es) Derivados de indol mono-o disustituidos como inhibidores de la replicacion viral del dengue
CR20160007A (es) Nuevos compuestos triciclicos
CU20130094A7 (es) Moduladores de la vía del complemento
ECSP088620A (es) 1h-indoles sustituidos por sulfonilo como ligandos para los receptores 5-hidroxitriptamina
PE20201500A1 (es) Inhibidores de glicolato oxidasa para el tratamiento de enfermedades
MX343611B (es) Composicion de control de fitoenfermedades y su uso.
MX2019001376A (es) Composicion de liberacion modificada de orlistat y acarbosa para el tratamiento de la obesidad y trastornos metabolicos relacionados.
MX374295B (es) Sal de maleato de agonista de tlr7, sus formas cristalinas c, d y e, sus métodos de preparación y usos de la sal de maleato y formas cristalinas.
UY31738A (es) Inhibidores a base de hidroxamato de desacetilasas b
UY33655A (es) Co-cristales y sales de inhibidores de ccr30
BR112012029882A2 (pt) novo processo para a síntese de tapentadol e intermediários do mesmo
PE20190964A1 (es) Inhibidores de dopamina-b-hidroxilasa penetrantes de la barrera hematoencefalica
CL2020000376A1 (es) Compuesto pentacíclico.
BR112017000417A2 (pt) processo para preparação de fenil alcanos substituídos
EA201692488A1 (ru) Пептиды, выполняющие роль агонистов окситоцина
AR099300A1 (es) Hexahidrofuropirroles como inhibidores de pde1
BR112016017816A8 (pt) derivados de etinila, seus usos, e composição farmacêutica
PE20180025A1 (es) Nuevas formas solidas de desvenlafaxina
MX2021000611A (es) Una sal de xinafoato de un compuesto inhibidor de jak.